The EPZM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EPZM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The EPZM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View EPZM Detailed Price Forecast - CNN Money||View EPZM Detailed Summary - Google Finance|
|View EPZM Detailed Summary - Yahoo! Finance||View EPZM Stock Research & Analysis - Zacks.com|
|View EPZM Trends & Analysis - Trade-Ideas||View EPZM Major Holders - Barrons|
|View EPZM Call Transcripts - NASDAQ||View EPZM Breaking News & Analysis - Seeking Alpha|
|View EPZM Annual Report - CompanySpotlight.com||View EPZM OTC Short Report - OTCShortReport.com|
|View EPZM Fundamentals - TradeKing||View EPZM SEC Filings - Bar Chart|
|View Historical Prices for EPZM - The WSJ||View Performance/Total Return for EPZM - Morningstar|
|View the Analyst Estimates for EPZM - MarketWatch||View the Earnings History for EPZM - CNBC|
|View the EPZM Earnings - StockMarketWatch||View EPZM Buy or Sell Recommendations - MacroAxis|
|View the EPZM Bullish Patterns - American Bulls||View EPZM Short Pain Metrics - ShortPainBot.com|
|View EPZM Stock Mentions - StockTwits||View EPZM Stock Mentions - PennyStockTweets|
|View EPZM Stock Mentions - Twitter||View EPZM Investment Forum News - Investor Hub|
|View EPZM Stock Mentions - Yahoo! Message Board||View EPZM Stock Mentions - Seeking Alpha|
|View Insider Transactions for EPZM - SECform4.com||View Insider Transactions for EPZM - Insider Cow|
|View EPZM Major Holdings Summary - CNBC||View Insider Disclosure for EPZM - OTC Markets|
|View Insider Transactions for EPZM - Yahoo! Finance||View Institutional Holdings for EPZM - NASDAQ|
|View EPZM Stock Insight & Charts - FinViz.com||View EPZM Investment Charts - StockCharts.com|
|View EPZM Stock Overview & Charts - BarChart||View EPZM User Generated Charts - Trading View|
Epizyme Announces Closing of Concurrent Public Offerings and Full Exercise of Underwriter’s Option to Purchase Additional Shares
Posted on Tuesday March 12, 2019
Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced the closing of its two concurrent underwritten public offerings of 11,500,000 shares of its common stock and 350,000 shares of its non-voting Series A Convertible Preferred Stock, which includes the full exercise by the underwriters of their separate options in each of the respective offerings to purchase additional shares at the public offering price. The public offering price of each share of common stock was $11.50 and the public offering price of each share of Series A stock was $115.00. The aggregate gross proceeds to Epizyme from the offerings, before deducting underwriting discounts and offering expenses, are $172.50 million.
Does Epizyme, Inc.’s (NASDAQ:EPZM) CEO Salary Compare Well With Others?
Posted on Friday March 08, 2019
Rob Bazemore has been the CEO of Epizyme, Inc. (NASDAQ:EPZM) since 2015. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that,Read More...
Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock
Posted on Wednesday March 06, 2019
Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced the pricing of two concurrent underwritten public offerings of (i) 10,000,000 shares of its common stock and (ii) 304,348 shares of its non-voting Series A Convertible Preferred Stock. Epizyme anticipates the total gross proceeds from the offering (before deducting underwriting discounts and offering expenses) will be approximately $150 million, excluding any exercise of the underwriters' options to purchase additional shares and before deducting underwriting discounts and offering expenses. The public offering price of each share of common stock is $11.50 and the public offering price of each share of Series A stock is $115.00.
Epizyme Announces Proposed Concurrent Public Offerings of Common Stock and Series A Preferred Stock
Posted on Wednesday March 06, 2019
Epizyme, Inc. (EPZM), a late-stage company developing novel epigenetic therapies, today announced that it intends to offer and sell shares of its common stock and Series A convertible preferred stock in two concurrent but separate underwritten public offerings. The offerings are being made by means of separate preliminary prospectus supplements and are not contingent upon each other. Epizyme also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock and preferred stock offered in the offering.